Mechanisms involved in the desflurane-induced post-conditioning of isolated human right atria from patients with type 2 diabetes

British Journal of Anaesthesia

Volumn 107, Issue 4, 2011, Pages 510-518

  Lemoine, S ^a   Zhu, L ^b   Buleon C ^b   Massetti, M ^c   Gerard J L ^a,b   Galera, P ^c   Hanouz, J L ^a,b  

^a UNIVERSITÉ DE CAEN   (France)

^b Department of Anaesthesiology and Intensive Care ^*  (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Desflurane; diabetes; myocardium; post conditioning

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALPHOSTIN C; DESFLURANE; DIAZOXIDE; GLYCOGEN SYNTHASE KINASE 3BETA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE B; PROTEIN KINASE C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FORCE OF CONTRACTION; HUMAN; HYPOXIA; IN VITRO STUDY; ISCHEMIC POSTCONDITIONING; ISOMETRICS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REOXYGENATION; WESTERN BLOTTING;

EID: 80052628663     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer201     Document Type: Article

References (34)

1. Woods SE, Eppley C, Engel A. The influence of diabetes mellitus in patients undergoing coronary artery bypass graft surgery: a prospective cohort study. Am Surg 2008; 74: 839-44
2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34 (Pubitemid 28350165)
3. Canbaz S, Duran E. Ischaemia-reperfusion studies and diabetes mellitus. Br J Anaesth 2003; 91: 158-9
4. Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005; 103: 687-94 (Pubitemid 41415516)
5. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 2000; 278: H1218-24 (Pubitemid 30235499)
6. Matsumoto S, Cho S, Tosaka S, et al. Pharmacological preconditioning in type 2 diabetic rat hearts: the roles of mitochondrial ATP-sensitive potassium channels and the phosphatidylinositol 3-kinase-Akt pathway. Cardiovasc Drugs Ther 2009; 23: 263-70
7. Hassouna A, Loubani M, Matata BM, Fowler A, Standen NB, Galinanes M. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res 2006; 69: 450-8 (Pubitemid 43098801)
8. Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, Preckel B. Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 2008; 100: 465-71 (Pubitemid 351773615)
9. Lemoine S, Durand C, Zhu L, et al. Desflurane-induced postconditioning of diabetic human right atrial myocardium in vitro. Diabetes Metab 2010; 36: 21-8.
10. Lemoine S, Beauchef G, Zhu L, et al. Signaling pathways involved in desflurane-induced postconditioning in human atrial myocardium in vitro. Anesthesiology 2008; 109: 1036-44
11. Lemoine S, Puddu PE, Durand C, et al. Signaling pathways involved in postconditioning-induced cardioprotection of human myocardium, in vitro. Exp Biol Med (Maywood) 2010; 235: 768-76
12. Monteiro P, Gonçalves L, Providência LA. Diabetes and cardiovascular disease: the road to cardioprotection. Heart 2005; 91: 1621-5 (Pubitemid 41697616)
13. Moon CH, Jung YS, Lee SH, Baik EJ. Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury. Jpn J Physiol 1999; 49: 409-15
14. Ooie T, Takahashi N, Nawata T, et al. Ischemia-induced translocation of protein kinase C-epsilon mediates cardioprotection in the streptozotocin-induced diabetic rat. Circ J 2003; 67: 955-61 (Pubitemid 37370247)
15. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 2007; 116: 173-91. (Pubitemid 47451505)
16. Ghosh S, Standen NB, Galinanes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001; 37: 711-8. (Pubitemid 32202434)
17. Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 2007; 292: R920-6 (Pubitemid 46207749)
18. Kersten JR, Montgomery MW, Ghassemi T, et al. Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 2001; 280: H1744-50
19. Tanaka K, Kehl F, Gu W, et al. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 2002; 282: H2018-23 (Pubitemid 34663008)
20. Hanley PJ, Mickel M, Löffler M, Brandt U, Daut J. KATP channelindependent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 2002; 542: 735-41 (Pubitemid 34947269)
21. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol 2002; 545: 961-74 (Pubitemid 36024433)
22. Schä fer G, Wegener C, Portenhauser R, Bojanovski D. Diazoxide, an inhibitor of succinate oxidation. Biochem Pharmacol 1969; 18: 2678-81
23. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3b during preconditioning through a phosphatidylinositol-3- kinase dependent pathway is cardioprotective. Circ Res 2002; 90: 377-9 (Pubitemid 34633905)
24. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3b. Anesthesiology 2005; 103: 987-95 (Pubitemid 41552054)
25. Gross ER, Hsu AK, Gross GJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3b. Diabetes 2007; 56: 127-36
26. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2005; 54: 2360-4 (Pubitemid 41134263)
27. Lauzier B, Delemasure S, Debin R, et al. Beneficial effects of myocardial postconditioning are associated with reduced oxidative stress in a senescent mouse model. Transplantation 2008; 85: 1802-8
28. Przyklenk K, Maynard M, Darling CE, Whittaker P. Aging mouse hearts are refractory to infarct size reduction with postconditioning. J Am Coll Cardiol 2008; 51: 1393-8 (Pubitemid 351443077)
29. Boengler K, Buechert A, Heinen Y, et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 2008; 102: 131-5
30. Gao F, Gao E, Yue TL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002; 105: 1497-502
31. Gribble FM, Ashcroft FM. Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues. Metabolism 2000; 49: 3-6
32. Saito W, Noguchi K, Okazaki K, et al. Temperature-sensitive effects of potassium channel openers on isolated guinea pig myocardium and aorta. J Cardiovasc Pharmacol 1998; 31: 327-9 (Pubitemid 28099176)
33. Dow J, Bhandari A, Kloner RA. Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heart. J Cardiovasc Pharmacol Ther 2008; 13: 141-8 (Pubitemid 351704170)
34. Sivaraman V, Mudalgiri NR, Di Salvo C, et al. Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res Cardiol 2007; 102: 453-9 (Pubitemid 47278818)